RVTY

Revvity Inc
$168.46+$16.86+11.12%Price as of Nov 3, 2026, 9:45 AM ET

Key stats

Market cap
18.8B
Open
—
Day range
—
52-week range
$81.22 – $169.06
Volume
711K
Avg volume
1.77M

Earnings

Q3 FY26Beat
Expected$1.33
Actual$1.38
Q2 FY26
Actual$0.47
Q1 FY26
Actual$0.36
Q4 FY25
Actual$0.87

Next earnings call Jan 28, 2027

About

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Employees
11,000
Headquarters
Waltham, MA